⌘K

Login Start Free

Home/Filings/4/0001437749-21-027706

4//SEC Filing

Kunin Audrey 4

Accession 0001437749-21-027706

CIK 0001389545other

View on SEC.gov Company Profile

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 4:30 PM ET

Size

4.5 KB

Accession

0001437749-21-027706

Insider Transaction Report

Form 4

Period: 2021-11-30

NovaBay Pharmaceuticals, Inc.NBY

Chief Product Officer

Transactions

Purchase
Common Stock
2021-11-30$0.46/sh+30,000$13,800→ 121,133 total(indirect: See footnote)

Footnotes (1)

[F1]By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.

Documents

1 file

4
rdgdoc.xmlPrimary
FORM 4

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeother

Related Parties

1

filerCIK 0001738781

Filing Metadata

Form type: 4
Filed: Dec 1, 7:00 PM ET
Accepted: Dec 2, 4:30 PM ET
Size: 4.5 KB

View on SEC.gov